These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32242356)

  • 21. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
    Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA
    Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anatomic, Geographic, and Taxon-Specific Relative Risks of Carbapenem Resistance in the Health Care System of the U.S. Department of Defense.
    Lesho E; Chukwuma U; Sparks M; Neumann C; Richesson D; Clifford R; Gierhart S; Waterman P; Hinkle M
    J Clin Microbiol; 2016 Jun; 54(6):1546-1551. PubMed ID: 27030488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States.
    Nelson RE; Hatfield KM; Wolford H; Samore MH; Scott RD; Reddy SC; Olubajo B; Paul P; Jernigan JA; Baggs J
    Clin Infect Dis; 2021 Jan; 72(Suppl 1):S17-S26. PubMed ID: 33512523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
    Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
    Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).
    Pfaller MA; Carvalhaes CG; Smith CJ; Diekema DJ; Castanheira M
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115016. PubMed ID: 32111415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial infections in Intensive Care Unit patients analyzed on the example of the Lodz Medical University Hospital No 1 in the period 2002-2015.
    Tyczkowska-Sieron R; Bartoszko-Tyczkowska A; Gaszynski W
    Med Dosw Mikrobiol; 2016; 68(1):39-46. PubMed ID: 28146621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
    Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.
    Jones BE; Brown KA; Jones MM; Huttner BD; Greene T; Sauer BC; Madaras-Kelly K; Rubin MA; Bidwell Goetz M; Samore MH
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):937-944. PubMed ID: 28633678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS).
    Maechler F; Peña Diaz LA; Schröder C; Geffers C; Behnke M; Gastmeier P
    Infection; 2015 Apr; 43(2):163-8. PubMed ID: 25395161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.
    Polly M; de Almeida BL; Lennon RP; Cortês MF; Costa SF; Guimarães T
    Am J Infect Control; 2022 Jan; 50(1):32-38. PubMed ID: 34562526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors.
    Gruber I; Heudorf U; Werner G; Pfeifer Y; Imirzalioglu C; Ackermann H; Brandt C; Besier S; Wichelhaus TA
    Int J Med Microbiol; 2013 Dec; 303(8):405-9. PubMed ID: 23770266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteremia caused by multidrug-resistant bacteria in a French university hospital center: 3 years of collection.
    Picot-Guéraud R; Batailler P; Caspar Y; Hennebique A; Mallaret MR
    Am J Infect Control; 2015 Sep; 43(9):960-4. PubMed ID: 26082260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study.
    Tacconelli E; De Angelis G; Cataldo MA; Mantengoli E; Spanu T; Pan A; Corti G; Radice A; Stolzuoli L; Antinori S; Paradisi F; Carosi G; Bernabei R; Antonelli M; Fadda G; Rossolini GM; Cauda R
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4264-9. PubMed ID: 19667289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
    Cleland H; Tracy LM; Padiglione A; Stewardson AJ
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review.
    Abubakar U; Al-Anazi M; Alanazi Z; Rodríguez-Baño J
    J Infect Public Health; 2023 Mar; 16(3):320-331. PubMed ID: 36657243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
    Huang X; Li G; Yi L; Li M; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial resistance and pathogen distribution in hospitalized burn patients: A multicenter study in Southeast China.
    Li L; Dai JX; Xu L; Chen ZH; Li XY; Liu M; Wen YQ; Chen XD
    Medicine (Baltimore); 2018 Aug; 97(34):e11977. PubMed ID: 30142829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal colonization with antimicrobial-resistant bacteria among women in labor in central Uganda: prevalence and associated factors.
    Tumuhamye J; Steinsland H; Bwanga F; Tumwine JK; Ndeezi G; Mukunya D; Namugga O; Kasede AN; Sommerfelt H; Nankabirwa V
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):37. PubMed ID: 33597029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012.
    Williams V; Simor AE; Kiss A; McGeer A; Hirji Z; Larios OE; Moore C; Weiss K;
    Clin Microbiol Infect; 2015 Jun; 21(6):553-9. PubMed ID: 25677630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.